To examine the clinical relevance of this finding, we analyzed FYN expression in sarcoma patients (Hoadley et al., 2018) and found that FYN mRNA levels are significantly lower in synovial sarcoma than in any type of sarcomas that do not carry the SS18-SSX fusion (Figure 2D). The gene discussed is SSX2; the disease is sarcoma.